FIFTH THIRD BANCORP - MERIDIAN BIOSCIENCE INC ownership

MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 172 filers reported holding MERIDIAN BIOSCIENCE INC in Q3 2016. The put-call ratio across all filers is 3.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
FIFTH THIRD BANCORP ownership history of MERIDIAN BIOSCIENCE INC
ValueSharesWeighting
Q4 2022$153,895
+6.1%
4,634
+0.7%
0.00%0.0%
Q3 2022$145,000
+3.6%
4,6010.0%0.00%0.0%
Q2 2022$140,000
+17.6%
4,6010.0%0.00%
Q1 2022$119,000
+26.6%
4,6010.0%0.00%
Q4 2021$94,000
+9.3%
4,601
+2.8%
0.00%
Q3 2021$86,000
-11.3%
4,474
+2.3%
0.00%
Q2 2021$97,000
-15.7%
4,3750.0%0.00%
-100.0%
Q1 2021$115,000
+32.2%
4,375
-6.4%
0.00%
Q4 2020$87,000
-93.1%
4,675
-93.7%
0.00%
-100.0%
Q3 2020$1,263,000
-27.1%
74,3750.0%0.01%
-30.0%
Q2 2020$1,732,000
+41.7%
74,375
-48.9%
0.01%
+11.1%
Q1 2020$1,222,000
-27.1%
145,480
-15.2%
0.01%0.0%
Q4 2019$1,677,000
+4.5%
171,606
+1.5%
0.01%
-10.0%
Q3 2019$1,605,000
-20.1%
169,1060.0%0.01%
-16.7%
Q2 2019$2,009,000
-18.8%
169,106
+20.4%
0.01%
-25.0%
Q1 2019$2,473,000
+12.7%
140,413
+11.0%
0.02%0.0%
Q4 2018$2,195,000
+16.5%
126,4450.0%0.02%
+33.3%
Q3 2018$1,884,000
-6.6%
126,445
-0.3%
0.01%
-14.3%
Q2 2018$2,017,000
-19.5%
126,858
-28.1%
0.01%
-17.6%
Q1 2018$2,506,000
-35.3%
176,498
-36.2%
0.02%
-34.6%
Q4 2017$3,871,000
-2.1%
276,4980.0%0.03%
-7.1%
Q3 2017$3,954,000
+15.7%
276,498
+27.5%
0.03%
+12.0%
Q2 2017$3,416,000
+14.2%
216,903
+0.0%
0.02%
+8.7%
Q1 2017$2,992,000
-22.0%
216,8130.0%0.02%
-25.8%
Q4 2016$3,838,000
-34.6%
216,813
-28.8%
0.03%
-36.7%
Q3 2016$5,870,000
-14.4%
304,313
-13.5%
0.05%
-15.5%
Q2 2016$6,861,000
-25.8%
351,869
-21.6%
0.06%
-27.5%
Q1 2016$9,248,000
-3.1%
448,728
-3.5%
0.08%
-4.8%
Q4 2015$9,543,000
+16.4%
465,066
-3.0%
0.08%
+10.5%
Q3 2015$8,195,000
-8.6%
479,257
-0.4%
0.08%
-2.6%
Q2 2015$8,967,000
-2.3%
481,064
+0.0%
0.08%
-1.3%
Q1 2015$9,179,000
+16.5%
481,063
+0.5%
0.08%
+17.9%
Q4 2014$7,877,000
-6.5%
478,572
+0.5%
0.07%
-13.0%
Q3 2014$8,428,000
-13.7%
476,419
+0.7%
0.08%
-12.5%
Q2 2014$9,761,000
+227.1%
472,934
+245.3%
0.09%
+214.3%
Q1 2014$2,984,000
-17.0%
136,951
+1.1%
0.03%
-20.0%
Q4 2013$3,594,000
+12.1%
135,471
-0.2%
0.04%
+6.1%
Q3 2013$3,207,000
+10.1%
135,710
+0.1%
0.03%
+6.5%
Q2 2013$2,913,000135,5100.03%
Other shareholders
MERIDIAN BIOSCIENCE INC shareholders Q3 2016
NameSharesValueWeighting ↓
SYQUANT CAPITAL SAS 134,804$4,47711.01%
Vazirani Asset Management LLC 115,774$3,8456.51%
FIFTH LANE CAPITAL, LP 185,914$6,174,2045.56%
NEXPOINT ASSET MANAGEMENT, L.P. 1,939,075$64,396,6815.01%
Crystalline Management Inc. 244,453$8,118,2844.08%
FNY Investment Advisers, LLC 51,000$1,6932.36%
HAVENS ADVISORS LLC 26,800$890,0282.26%
Euclidean Technologies Management, LLC 62,995$2,092,0641.99%
Sand Grove Capital Management LLP 537,060$17,8361.70%
Crabel Capital Management, LLC 120,337$3,9961.45%
View complete list of MERIDIAN BIOSCIENCE INC shareholders